Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/20/23 04:05:00 on US and Canada Markets.
DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) , a fully integrated biopharmaceutical company specializing in the end-to-end development, manufacturing, and commercialization of innovative therapies, today provided strategic, financial, and...
Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants. The initiative, which is a component of Oscar’s CCC Program, delivers financial and on-the-ground sup...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it is scheduled to present at the 6 th annual Evercore ISI H...
PENSKE AUTOMOTIVE GROUP PUBLISHES 2023 CORPORATE RESPONSIBILITY REPORT PR Newswire BLOOMFIELD HILLS, Mich. , Nov. 20, 2023 /PRNewswire/ -- Penske Automotive Group, Inc. (NYSE: PAG), a diversified international transportation services company and one of the world'...
Domino's® To Host Investor Day on Thursday, December 7 PR Newswire ANN ARBOR, Mich. , Nov. 20, 2023 /PRNewswire/ -- Domino's Pizza, Inc. (NYSE:DPZ) On December 7, 2023 , Domino's will host an Investor Day from 9:00 a.m. to 12:00 p.m...
SOMERSET, N.J., Nov. 20, 2023 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, announced today its Arculus Authenticate hardware passkeys received designation as a Microsoft FIDO2 security key vendor . Arculus...
HINGHAM, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ:HIFS) (“the Bank”), Hingham, Massachusetts, announced that its Board of Directors has declared a regular quarterly cash dividend of $0.63 per share. The dividend will be paid on...
Epilepsia publishes two-year open-label extension Marigold trial data of ZTALMY ® (ganaxolone) oral suspension CV in patients with CDKL5 deficiency disorder (CDD) In preliminary results from a Phase 1 multiple ascending dose (MAD) study, the second generation ganaxolone formula...
Initiated a Phase 2a Challenge Study of EDP-323, an L-Protein Inhibitor, in Development as an Oral, Once-Daily Treatment for Respiratory Syncytial Virus (RSV); Expect to Report Data in Q3 2024 Streamlined Business and Significantly Lowered 2024 R&D and G&A Spending Guidance to...
Concord Medical Schedules 2023 Annual Meeting of Shareholders PR Newswire BEIJING , Nov. 20, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, re...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
10.43%Change Percent:
Ecolab Inc. Company Name:
ECL Stock Symbol:
NYSE Market:
ecolab.com Website: